Abstract
MicroRNAs (miRNAs), the endogenous noncoding RNAs, are involved in carcinogenesis. Laryngeal squamous cell carcinoma (LSCC) is the common cancer in head and neck. Whether miRNAs can be used in the diagnosis of LSCC is largely unknown. The purpose of this study was to identify whether miRNAs could be use as potential biomarkers for LSCC diagnosis. The expression levels of miR-21, miR-106b and miR-375, in LSCC tissues and paired nontumor tissues were first quantitatively analyzed by reverse transcription-polymerase chain reaction. Then, the relationships between their expression levels and clinicopathological parameters of patients with LSCC were further determined. We found that these miRNAs’ expression levels were significantly different between LSCC tissues and adjacent normal tissues. Two miRNAs, miR-21 and miR-106b were found up-regulated in cancer tissues (P=0.0012 and P<0.001, respectively), while miR-375 down-regulated (P<0.001). Moreover, miR-21 and miR-106b levels were found significantly increased in poorly (G3)/moderately differentiated (G2) cancer tissues comparing with well differentiated (G1) and dysplasia (D) tissues (P<0.001, respectively). Their levels were also positively associated with lymph node metastasis (P<0.05) and TNM stages (P<0.01). However, miR-375 expression level was only found negatively associated with TNM stages. Our preliminary data suggest that three miRNAs, miR-21, miR-106b and miR- 375 might become novel tumor markers for LSCC diagnosis.
Keywords: Laryngeal squamous cell carcinoma, MicroRNAs, MiR-21, MiR-106b, MiR-375, tumor markers.
Current Pharmaceutical Biotechnology
Title:miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma
Volume: 15 Issue: 5
Author(s): Xing Yu, Yibo Wu, Yang Liu, Hongxia Deng, Zhisen Shen, Bingxiu Xiao and Junming Guo
Affiliation:
Keywords: Laryngeal squamous cell carcinoma, MicroRNAs, MiR-21, MiR-106b, MiR-375, tumor markers.
Abstract: MicroRNAs (miRNAs), the endogenous noncoding RNAs, are involved in carcinogenesis. Laryngeal squamous cell carcinoma (LSCC) is the common cancer in head and neck. Whether miRNAs can be used in the diagnosis of LSCC is largely unknown. The purpose of this study was to identify whether miRNAs could be use as potential biomarkers for LSCC diagnosis. The expression levels of miR-21, miR-106b and miR-375, in LSCC tissues and paired nontumor tissues were first quantitatively analyzed by reverse transcription-polymerase chain reaction. Then, the relationships between their expression levels and clinicopathological parameters of patients with LSCC were further determined. We found that these miRNAs’ expression levels were significantly different between LSCC tissues and adjacent normal tissues. Two miRNAs, miR-21 and miR-106b were found up-regulated in cancer tissues (P=0.0012 and P<0.001, respectively), while miR-375 down-regulated (P<0.001). Moreover, miR-21 and miR-106b levels were found significantly increased in poorly (G3)/moderately differentiated (G2) cancer tissues comparing with well differentiated (G1) and dysplasia (D) tissues (P<0.001, respectively). Their levels were also positively associated with lymph node metastasis (P<0.05) and TNM stages (P<0.01). However, miR-375 expression level was only found negatively associated with TNM stages. Our preliminary data suggest that three miRNAs, miR-21, miR-106b and miR- 375 might become novel tumor markers for LSCC diagnosis.
Export Options
About this article
Cite this article as:
Yu Xing, Wu Yibo, Liu Yang, Deng Hongxia, Shen Zhisen, Xiao Bingxiu and Guo Junming, miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma, Current Pharmaceutical Biotechnology 2014; 15 (5) . https://dx.doi.org/10.2174/1389201015666140519110616
DOI https://dx.doi.org/10.2174/1389201015666140519110616 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Target Genetic Abnormalities for the Treatment of Colon Cancer and Its Progression to Metastasis
Current Drug Targets Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Evaluating the Diagnostic and Chemotherapeutic Potential of Vancomycin- Derived Imaging Conjugates
Medicinal Chemistry Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Current Cancer Drug Targets The Tumor Suppressor Gene ARF as a Sensor of Oxidative Stress
Current Molecular Medicine Synthesis and Biological Evaluation of 1, 3-Dihydroxyxanthone Mannich Base Derivatives as Potential Antitumor Agents
Letters in Drug Design & Discovery Molecular Mechanisms Underlying St. Johns Wort Drug Interactions
Current Drug Metabolism Assembled Core-Shell Nanostructures of Gold Nanoparticles with Biocompatible Polymers Toward Biology
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Proteomic Signatures for Cancer Personalized Medicine)
Current Proteomics Investigation of Human Papilloma Virus Associated with Oral Cancer with an Insight into Diagnostic Approaches and Recent Patents
Recent Patents on Biomarkers 18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry
Current Radiopharmaceuticals Respiratory Stem Cells and Progenitors: Overview, Derivation, Differentiation, Carcinogenesis, Regeneration and Therapeutic Application
Current Stem Cell Research & Therapy Hypericin - The Facts About a Controversial Agent
Current Pharmaceutical Design Chemistry and Health Effects of Bioactive Compounds in Selected Culinary Aromatic Herbs
Current Nutrition & Food Science Maxillary Metastasis of Esophageal Cancer: Report of the First Case and Literature Review
Combinatorial Chemistry & High Throughput Screening Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents
Current Medicinal Chemistry Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity
Mini-Reviews in Medicinal Chemistry Meta-analysis Reveals No Association of DNMT3B -149 C>T Gene Polymorphism With Overall Cancer Risk
Current Genomics Novel Insights Into c-Src
Current Pharmaceutical Design The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells
Anti-Cancer Agents in Medicinal Chemistry